Business Business.- In recent years, people have sought to enhance their beauty and appearance, improving some imperfections, which makes aesthetic medicine the perfect ally in skin care. In this sense, the second-generation recombinant enzyme is ideal for the treatment of facial and body localized fat, laxity, hypertrophic scars and keloids.
“These enzymes are unique active ingredients, 100% biological, derived from genetic engineering, and one of the latest innovations in aesthetic medicine to eliminate cellulite, fibrosis, sagging and improve stretch marks or scars. It is a minimally invasive injection There is no need to go through the operating room for surgery.” Giulianna Berrocal, specialist at the Center of Aesthetic Medicine of the Ricardo Palma Clinic.
The expert explains that the second generation PB Serum treatment is based on an enzyme consisting of: collagenase (stimulates collagen regeneration, has firming and anti-aging effects), lipase (reduces fat), lytic enzymes and hyaluronic acid (two Both are necessary to restore) the optimal shape of the skin).
These enzymes serve multiple purposes, and second-generation enzymes are compartmentalized and focused on specific roles, such as:
- PB serum low: Focuses on contouring, redefining and restoring facial contours.
- PB serum medium: Specifically designed to treat body obesity with double chin or double chin, arms, back, abdomen and cellulite. In addition, it improves the face through enzymatic double cheek resection without going to the operating room.
- PB serum high: It is recommended for the lightening of scars in general (post-acne), the reduction of fibrosis after fat surgery, the tightening of facial and body skin, and the elimination of fibrosis of cellulite.
It should be emphasized that the application of these second-generation recombinant enzymes must be instructed and performed by a professional, since the patient needs to be evaluated individually for each case beforehand. The specialist will also determine the number of sessions needed and assess whether other complementary treatments are necessary to optimize results.